Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rudolph

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Dermatology (Basel, Switzerland)|May 16, 2002
Antimicrobial effectiveness of povidone-iodine and consequences for new application areasK Reimer, T A Wichelhaus, V Schäfer, et al.
The American Journal of Pathology|February 1, 1988
Multinucleated giant cells generated in vitro. Terminally differentiated macrophages with down-regulated c-fms expressionH Kreipe, H J Radzun, P Rudolph, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 31, 2001
Correlation between the expression of DNA topoisomerases I and IIalpha and clinical parameters in kidney diseaseL V Ivanova, P Rudolph, Y M Shilov, et al.
Journal of Immunological Methods|March 24, 1999
Immunoenzymatic detection of the new proliferation associated protein p100 by means of a cellular ELISA: specific detection of cells in cell cycle phases S, G2 and MS O Frahm, P Rudolph, C Dworeck, et al.
The Journal of Pathology|June 12, 1999
Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implicationsP Rudolph, H Olsson, G Bonatz, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|March 30, 1999
Comparative analysis of prognostic indicators for sarcomas of the soft parts and the visceraeP Rudolph, F Bonichon, K Gloeckner, et al.
Journal of the National Cancer Institute|February 26, 1999
Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancerP Rudolph, P Alm, H J Heidebrecht, et al.
Developments in Ophthalmology|September 19, 2002
Prophylactic indications for eye antiseptics. Prophylaxis against ophthalmia neonatorumA Kramer, C Aspöck, O Assadian, et al.
Human Pathology|June 30, 2001
High telomerase activity is associated with cell cycle deregulation and rapid progression in endometrioid adenocarcinoma of the uterusG Bonatz, S O Frahm, W Klapper, et al.
American Journal of Clinical Oncology|June 1, 1994
Hepatic and serologic toxicity of systemic interleukin-2 and/or interferon-alpha. Evidence of a risk-benefit advantage of subcutaneous therapyA Schomburg, H Kirchner, E Lopez-Hänninen, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Dermatology (Basel, Switzerland)|May 16, 2002
Antimicrobial effectiveness of povidone-iodine and consequences for new application areasK Reimer, T A Wichelhaus, V Schäfer, et al.
The American Journal of Pathology|February 1, 1988
Multinucleated giant cells generated in vitro. Terminally differentiated macrophages with down-regulated c-fms expressionH Kreipe, H J Radzun, P Rudolph, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 31, 2001
Correlation between the expression of DNA topoisomerases I and IIalpha and clinical parameters in kidney diseaseL V Ivanova, P Rudolph, Y M Shilov, et al.
Journal of Immunological Methods|March 24, 1999
Immunoenzymatic detection of the new proliferation associated protein p100 by means of a cellular ELISA: specific detection of cells in cell cycle phases S, G2 and MS O Frahm, P Rudolph, C Dworeck, et al.
The Journal of Pathology|June 12, 1999
Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implicationsP Rudolph, H Olsson, G Bonatz, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|March 30, 1999
Comparative analysis of prognostic indicators for sarcomas of the soft parts and the visceraeP Rudolph, F Bonichon, K Gloeckner, et al.
Journal of the National Cancer Institute|February 26, 1999
Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancerP Rudolph, P Alm, H J Heidebrecht, et al.
Developments in Ophthalmology|September 19, 2002
Prophylactic indications for eye antiseptics. Prophylaxis against ophthalmia neonatorumA Kramer, C Aspöck, O Assadian, et al.
Human Pathology|June 30, 2001
High telomerase activity is associated with cell cycle deregulation and rapid progression in endometrioid adenocarcinoma of the uterusG Bonatz, S O Frahm, W Klapper, et al.
American Journal of Clinical Oncology|June 1, 1994
Hepatic and serologic toxicity of systemic interleukin-2 and/or interferon-alpha. Evidence of a risk-benefit advantage of subcutaneous therapyA Schomburg, H Kirchner, E Lopez-Hänninen, et al.
Pageof 10